Dl-Tryptophan

Dl-Tryptophan

SCHEMBL9488111

NC(=O)CC(N)C(=O)O.NC(=O)CC(N)C(=O)O.NC(Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.84
KDM4E B2RXH2 3/20 0.84
MAPT P10636 3/20 0.84
LMNA P02545 2/20 0.84
TSHR P16473 2/20 0.84
BLM P54132 2/20 0.84
PMP22 Q01453 2/20 0.84
MEN1 O00255 2/20 0.84
MPO P05164 1/20 0.84
HIF1A Q16665 1/20 0.84
SMN1; SMN2 Q16637 1/20 0.60
APAF1 O14727 1/20 0.59
POLB P06746 1/20 0.59
RECQL P46063 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59
HTR2A P28223 3/20 0.59
HTR1A P08908 2/20 0.59
HTR2C P28335 2/20 0.59
SLC6A4 P31645 2/20 0.59
HTR7 P34969 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Tryptophan SCHEMBL9407071 1.00 KMT2A (0.84) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL531307 1.00 KMT2A (0.84) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL3443032 1.00 KMT2A (0.84) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL5016074 1.00 KMT2A (0.84) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL4296800 0.96 KMT2A (0.78) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL28697957 0.95 KDM4E (0.76) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL1640623 0.92 KMT2A (0.94) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL1640625 0.92 KMT2A (0.94) KMT2AKDM4EMAPTLMNATSHR
Dl-Tryptophan SCHEMBL8020249 0.92 KMT2A (0.94) KMT2AKDM4EMAPTLMNATSHR
Tryptophan SCHEMBL7645018 0.92 KMT2A (0.94) KMT2AKDM4EMAPTLMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5229492-A Cloned streptococcal genes encoding protein G and their use to construct recombinant microorganisms to produce protein G PHARMACIA LKB BIOTECHNOLOGY AB (SE) 1993-07-20 US disclosed
EP-0363436-A4 CLONED PROTEIN G VARIANT GENES AND THE PROTEIN G VARIANTS EXPRESSED THEREFROM. GENEX CORP (US) 1990-06-26 EP disclosed
EP-0363436-A1 CLONED PROTEIN G VARIANT GENES AND THE PROTEIN G VARIANTS EXPRESSED THEREFROM Pharmacia LKB Biotechnology AB (SE) 1990-04-18 EP disclosed
EP-0293391-A4 CLONED STREPTOCOCCAL GENES ENCODING PROTEIN G AND THEIR USE TO CONSTRUCT RECOMBINANT MICROORGANISMS TO PRODUCE PROTEIN G. GENEX CORP (US) 1989-06-21 EP disclosed
WO-1988010306-A1 CLONED PROTEIN G VARIANT GENES AND THE PROTEIN G VARIANTS EXPRESSED THEREFROM GENEX CORPORATION (US) 1988-12-29 WO disclosed
EP-0293391-A1 CLONED STREPTOCOCCAL GENES ENCODING PROTEIN G AND THEIR USE TO CONSTRUCT RECOMBINANT MICROORGANISMS TO PRODUCE PROTEIN G Pharmacia LKB Biotechnology AB (SE) 1988-12-07 EP disclosed
WO-1987005025-A1 CLONED STREPTOCOCCAL GENES ENCODING PROTEIN G AND THEIR USE TO CONSTRUCT RECOMBINANT MICROORGANISMS TO PRODUCE PROTEIN G GENEX CORPORATION (US) 1987-08-27 WO disclosed